Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
SAFETY AND EFFECTIVENESS OF UPADACITINIB OR ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 48 WEEKS FROM THE SELECT-COMPARE STUDY Fleischmann, R., Enejosa, J., Song, I., Mysler, E., Bessette, L., Peterfy, C., Durez, P., Ostor, A., Li Yihan, Zhou, Y., Genovese, M. C. BMJ PUBLISHING GROUP. 2019: 744–45
View details for DOI 10.1136/annrheumdis-2019-eular.4258
View details for Web of Science ID 000472207102190